CA:BCT / BriaCell Therapeutics Corp. - Net Long/Short Value

BriaCell Therapeutics Corp.
CA ˙ TSX
4,49 CA$ ↓ -0,09 (-1,97%)
2026-06-04
DEL PRIS
CA:BCT / BriaCell Therapeutics Corp. - Net Long/Short Value
Denne side viser netto-lange/korte værdiansættelser for hver institutionel besiddelse, der er rapporteret via 13F- eller NPORT-ansøgninger. For at beregne netto lang/kort værdi tilføjer vi egenkapitalværdien til værdien af call-optionen og trækker put-optionsværdien fra. Fonde, der rapporterer korte lånte positioner, vil rapportere aktieværdier som negative. Lange nettopositioner vil have positive tal i kolonnen netto lange/korte, og korte nettopositioner vil have negative værdier i denne kolonne.
Ejer Egenkapitalværdi
($1000)
Opkaldsværdi
($1000)
Sæt værdi
($1000)
Netto Lang/Kort
($1000)
Iridian Asset Management Llc/ct
LuminArx Capital Management LP
FNY Investment Advisers, LLC
Sabby Management, Llc
Wells Fargo & Company/mn
Group One Trading, L.p.
Caitong International Asset Management Co., Ltd
Morgan Stanley
National Bank Of Canada /fi/
Allworth Financial LP
HHM Wealth Advisors, LLC
UBS Group AG
Royal Bank Of Canada
TD Waterhouse Canada Inc.
Federation des caisses Desjardins du Quebec
Cable Car Capital LLC
Ssa Swiss Advisors Ag
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:BCTX 3,26 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista